Teicoplanin-induced ototoxicity in Down's syndrome.
Maher
E R
ER
Hollman
A
A
Grüneberg
R N
RN
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004314:Down Syndrome / Q000150:complications*; D006020:Glycopeptides / Q000009:adverse effects; D034381:Hearing Loss / Q000139:chemically induced*; D006316:Hearing Loss, High-Frequency / Q000139:chemically induced*; D006801:Humans; D008297:Male; D013290:Streptococcal Infections / Q000188:drug therapy; D013298:Streptococcus sanguis / Q000302:isolation & purification; D017334:Teicoplanin
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D017334:Teicoplanin